 | $14.29 Million in Sales Expected for ImmunoGen, Inc. (NASDAQ:IMGN) This Quarter
www.americanbankingnews.com - May 30 at 1:30 AM |
 | ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status - Business Wire
www.businesswire.com - May 29 at 2:32 PM |
 | ImmunoGen Presents Initial Data at ASCO from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status
finance.yahoo.com - May 29 at 9:01 AM |
| ImmunoGen, Inc. (NASDAQ:IMGN) Expected to Post Earnings of -$0.18 Per Share
www.americanbankingnews.com - May 28 at 10:24 PM |
| ImmunoGen (NASDAQ:IMGN) vs. Aoxing Pharmaceutical (NASDAQ:AOXG) Head to Head Review
www.americanbankingnews.com - May 21 at 5:50 PM |
 | Why ImmunoGen Stock Jumped Today - The Motley Fool
www.fool.com - May 20 at 10:03 PM |
| ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference - Yahoo Finance
finance.yahoo.com - May 20 at 5:03 PM |
| ImmunoGen Announces Webcast of Presentation at Upcoming Jefferies Virtual Healthcare Conference
finance.yahoo.com - May 20 at 5:03 PM |
|
| Edited Transcript of IMGN earnings conference call or presentation 1-May-20 12:00pm GMT - Yahoo Finance
finance.yahoo.com - May 17 at 4:40 PM |
| Edited Transcript of IMGN earnings conference call or presentation 1-May-20 12:00pm GMT
finance.yahoo.com - May 17 at 4:40 PM |
| ImmunoGen to Present Preclinical Data on IMGN151 at AACR Virtual Annual Meeting - Business Wire
www.businesswire.com - May 15 at 11:32 AM |
| Canaccord Genuity Reiterates Buy Rating for ImmunoGen (NASDAQ:IMGN)
www.americanbankingnews.com - May 14 at 7:47 AM |
| ImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status - Business Wire
www.businesswire.com - May 13 at 9:29 PM |
| ImmunoGen Announces Initial Data from FORWARD II Study Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Recurrent Ovarian Cancer, Regardless of Platinum Status
finance.yahoo.com - May 13 at 9:29 PM |
| ImmunoGen, Inc. (NASDAQ:IMGN) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - May 9 at 3:04 AM |
| ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference - Business Wire
www.businesswire.com - May 7 at 1:19 PM |
| ImmunoGen Announces Webcast of Presentation at Upcoming RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 7 at 8:18 AM |
| $14.36 Million in Sales Expected for ImmunoGen, Inc. (NASDAQ:IMGN) This Quarter
www.americanbankingnews.com - May 7 at 2:07 AM |
| -$0.17 EPS Expected for ImmunoGen, Inc. (NASDAQ:IMGN) This Quarter
www.americanbankingnews.com - May 6 at 12:03 AM |
| ImmunoGen, Inc. (NASDAQ:IMGN) Just Reported, And Analysts Assigned A US$6.75 Price Target - Yahoo Finance
finance.yahoo.com - May 5 at 12:46 PM |
| ImmunoGen, Inc. (NASDAQ:IMGN) Just Reported, And Analysts Assigned A US$6.75 Price Target
finance.yahoo.com - May 5 at 12:46 PM |
| Why ImmunoGen Stock Jumped Today - Motley Fool
www.fool.com - May 4 at 9:43 PM |
| ImmunoGen (IMGN) Q1 Earnings and Sales Miss, Shares Down - Yahoo Finance
finance.yahoo.com - May 4 at 4:42 PM |
| ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
www.businesswire.com - May 4 at 4:42 PM |
| Such Is Life: How ImmunoGen (NASDAQ:IMGN) Shareholders Saw Their Shares Drop 57% - Yahoo Finance
finance.yahoo.com - May 4 at 4:42 PM |
| Such Is Life: How ImmunoGen (NASDAQ:IMGN) Shareholders Saw Their Shares Drop 57%
finance.yahoo.com - May 4 at 4:42 PM |
| ImmunoGen (IMGN) Q1 Earnings and Sales Miss, Shares Down
finance.yahoo.com - May 4 at 4:42 PM |
| ImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
finance.yahoo.com - May 4 at 4:42 PM |
|
| Why ImmunoGen Stock Jumped Today
finance.yahoo.com - May 4 at 4:42 PM |
| Immunogen Inc (IMGN) Q1 2020 Earnings Call Transcript - Motley Fool
www.fool.com - May 1 at 8:15 PM |
| Immunogen: Q1 Earnings Insights - Yahoo Finance
finance.yahoo.com - May 1 at 3:15 PM |
| Immunogen: Q1 Earnings Insights
finance.yahoo.com - May 1 at 3:15 PM |
| Immunogen Inc (IMGN) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 1 at 3:15 PM |
 | BRIEF-Immunogen Reports Recent Progress And First Quarter 2020 Financial Results - Reuters
www.reuters.com - May 1 at 10:08 AM |
 | ImmunoGen (IMGN) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
www.nasdaq.com - May 1 at 10:08 AM |
| ImmunoGen Reports Recent Progress and First Quarter 2020 Financial Results
finance.yahoo.com - May 1 at 10:08 AM |
| ImmunoGen Announces Conference Call to Discuss Its First Quarter 2020 Operating Results - Yahoo Finance
finance.yahoo.com - April 16 at 11:00 PM |
| ImmunoGen Announces Conference Call to Discuss Its First Quarter 2020 Operating Results
finance.yahoo.com - April 16 at 5:59 PM |
 | ImmunoGen: Tremendous Value In Your Turnaround Stock - Seeking Alpha
seekingalpha.com - March 25 at 2:06 PM |
| Why Is ImmunoGen (IMGN) Down 45.5% Since Last Earnings Report? - Yahoo Finance
finance.yahoo.com - March 16 at 2:54 AM |
| Why Is ImmunoGen (IMGN) Down 45.5% Since Last Earnings Report? - Nasdaq
www.nasdaq.com - March 15 at 1:52 PM |
| Why Is ImmunoGen (IMGN) Down 45.5% Since Last Earnings Report?
finance.yahoo.com - March 15 at 1:52 PM |
| ImmunoGen: A Potential Turnaround Story For 2020 - Seeking Alpha
seekingalpha.com - February 21 at 9:36 AM |
| Stock Market News for Feb 18, 2020 - Yahoo Finance
finance.yahoo.com - February 18 at 5:25 PM |
| Bellerophon Therapeutics leads healthcare gainers; ImmunoGen among losers - Seeking Alpha
seekingalpha.com - February 18 at 5:25 PM |
| Why ImmunoGen Shares Are Sinking Today - Motley Fool
www.fool.com - February 18 at 12:25 PM |
| Stock Market News for Feb 18, 2020
finance.yahoo.com - February 18 at 12:24 PM |
| Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMT - Yahoo Finance
finance.yahoo.com - February 18 at 12:29 AM |
| Edited Transcript of IMGN earnings conference call or presentation 14-Feb-20 1:00pm GMT
finance.yahoo.com - February 17 at 7:28 PM |
| ImmunoGen (IMGN) Q4 Earnings and Revenues Beat Estimates - Yahoo Finance
finance.yahoo.com - February 16 at 7:51 AM |
